Capecitabine for squamous cell carcinoma reduction in solid organ transplant recipients

Andrew D Breithaupt; David Beynet; Teresa Soriano

doi:10.1016/j.jdcr.2015.09.009

Capecitabine for squamous cell carcinoma reduction in solid organ transplant recipients

JAAD Case Rep. 2015 Nov 24;1(6):S16-8. doi: 10.1016/j.jdcr.2015.09.009. eCollection 2015 Nov.

Authors

Andrew D Breithaupt¹, David Beynet¹, Teresa Soriano¹

Affiliation

¹ Division of Dermatology, University of California, Los Angeles, California.

No abstract available

Keywords: 5-FU, 5-fluorouracil; NMSC, nonmelanoma skin cancer; SCC, squamous cell carcinoma; SOTR, solid organ transplant recipient; capecitabine (Xeloda); chemoprevention; solid organ transplant; squamous cell carcinoma.

Publication types

Case Reports